...
机译:局部晚期鼻咽癌患者体积调节疗法同步化学疗法的临床结果
Department of Radiation Oncology Hiroshima University Graduate School of Biomedical Sciences;
Department of Radiation Oncology Hiroshima University Graduate School of Biomedical Sciences;
Department of Clinical Support Section of Radiation Therapy Hiroshima University Hospital;
Department of Radiation Oncology Hiroshima University Graduate School of Biomedical Sciences;
Department of Radiation Oncology Hiroshima University Graduate School of Biomedical Sciences;
Department of Radiation Oncology Hiroshima University Graduate School of Biomedical Sciences;
Department of Radiation Oncology Hiroshima University Graduate School of Biomedical Sciences;
Department of Radiation Oncology Hiroshima University Graduate School of Biomedical Sciences;
Department of Radiation Oncology Hiroshima Prefectural Hospital;
Department of Otolaryngology Head and Neck Surgery Hiroshima University Graduate School of;
Department of Otolaryngology Head and Neck Surgery Hiroshima University Graduate School of;
Department of Radiation Oncology Hiroshima University Graduate School of Biomedical Sciences;
Nasopharyngeal carcinoma; Chemoradiotherapy; Volumetric modulated arc therapy; Dry mouth;
机译:局部晚期鼻咽癌患者体积调节疗法同步化学疗法的临床结果
机译:剂量体积参数的影响及临床因素对急性辐射口腔粘膜肌炎,对局部晚期鼻咽癌患者进行同步强度调制放射治疗和化学疗法治疗
机译:同步放化疗期间顺铂累积剂量对调强放疗时代晚期鼻咽癌患者临床结局的影响
机译:IL-12是一种有用的标记,可预测放疗中的临床结果:IL-12的下调增加了局部晚期肝细胞癌的治疗失败
机译:云芝丹参对乳腺癌和鼻咽癌患者及类风湿关节炎灵芝三妙散的免疫调节活性的临床研究。
机译:同步放化疗期间顺铂累积剂量对调强放疗时代晚期鼻咽癌患者临床结局的影响
机译:同步放化疗期间顺铂累积剂量对调强放疗时代晚期鼻咽癌患者临床结局的影响